Article title: A Longitudinal Echocardiographic Analysis of Patients Treated Using the Repositionable and Fully Retrievable Lotus Valve: A Sub-Analysis of the RESPOND Study
Authors: Osama Soliman, MD, PhD, Chun-Chin Chang, MD, Jochen Wöhrle, MD, David Hildick-Smith, MD, Sabine Bleiziffer, MD, Daniel J. Blackman, MD, Mohamed Abdel-Wahab, MD, PhD, Thomas Modine, MD, PhD, Andrey Nersesov, BS, Dominic J. Allocco, MD, Ian T. Meredith, AM, MBBS, PHD, Volkmar Falk, MD, and Nicolas M. Van Mieghem, MD, PhD for the RESPOND Study Investigators
Journal: Structural Heart
Bibliometrics: Volume 4, Number 1, pages 26-33
DOI: https://doi.org/10.1080/24748706.2019.1686556
IRB and consent information were not noted in the published article.
The following text has been added to the article:
As reported in the prior publication, the protocol was approved by the locally appointed institutional review boards/ethics committees and the study was conducted in accordance with the International Conference on Harmonization Guidelines for Good Clinical Practice and the ethical principles outlined in the Declaration of Helsinki. The study was sponsored by Boston Scientific Corporation and registered with ClinicalTrials.gov (NCT#02031302) and all patients gave written informed consent.